Cargando…

EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus

The EndoBarrier™ medical device is a duodenal-jejunal bypass liner designed to mimic the effects of gastric bypass surgery to induce weight loss and glycaemic improvement. In this study, 10 participants with type 2 diabetes mellitus (T2DM), a mean body mass index (BMI) of 43.3 ± 5.0 (kg/m(2)) and a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Obermayer, Anna, Tripolt, Norbert J., Aziz, Faisal, Högenauer, Christoph, Aberer, Felix, Schreiber, Florian, Eherer, Andreas, Sourij, Caren, Stadlbauer, Vanessa, Svehlikova, Eva, Brunner, Martina, Goswami, Nandu, Kojzar, Harald, Pferschy, Peter N., Pieber, Thomas R., Sourij, Harald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070956/ https://www.ncbi.nlm.nih.gov/pubmed/33919949 http://dx.doi.org/10.3390/biom11040574

Ejemplares similares

Impact of Duodeno-Jejunal Bypass Liner (EndoBarrierTM) Implantation on Insulin Sensitivity in Patients with Type 2 Diabetes Mellitus (T2DM): A Study Protocol for a Pilot Trial
por: Tripolt, Norbert Joachim, et al.
Publicado: (2018)

INTERmittent FASTing in people with insulin‐treated type 2 diabetes mellitus – the INTERFAST‐2 study protocol
por: Obermayer, Anna, et al.
Publicado: (2022)

Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)—A Randomized Controlled Trial
por: Obermayer, Anna, et al.
Publicado: (2023)

Impact of a Single 36 Hours Prolonged Fasting Period in Adults With Type 1 Diabetes – A Cross-Over Controlled Trial
por: Moser, Othmar, et al.
Publicado: (2021)

Performance of the Intermittently Scanned Continuous Glucose Monitoring (isCGM) System during a High Oral Glucose Challenge in Adults with Type 1 Diabetes—A Prospective Secondary Outcome Analysis
por: Moser, Othmar, et al.
Publicado: (2021)

Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study
por: Aberer, Felix, et al.
Publicado: (2019)

Improved glycaemic variability and basal insulin dose reduction during a running competition in recreationally active adults with type 1 diabetes—A single-centre, prospective, controlled observational study
por: Moser, Othmar, et al.
Publicado: (2020)

Rapid glucose rise reduces heart rate variability in adults with type 1 diabetes: A prospective secondary outcome analysis
por: Eckstein, Max L., et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC‐DM cohort study
por: Sourij, Caren, et al.
Publicado: (2022)

Only Subclinical Alterations in the Haemostatic System of People with Diabetes after COVID-19 Vaccination
por: Paar, Margret, et al.
Publicado: (2022)

Glucose Metabolism and Metabolomic Changes in Response to Prolonged Fasting in Individuals with Obesity, Type 2 Diabetes and Non-Obese People—A Cohort Trial
por: Tripolt, Norbert J., et al.
Publicado: (2023)

Humoral immune response to COVID‐19 vaccination in diabetes is age‐dependent but independent of type of diabetes and glycaemic control: The prospective COVAC‐DM cohort study
por: Sourij, Caren, et al.
Publicado: (2022)

Simplified Acute Physiology Score 3 Performance in Austrian COVID-19 Patients Admitted to Intensive Care Units with and without Diabetes
por: Aziz, Faisal, et al.
Publicado: (2022)

Pre-Exercise Blood Glucose Levels Determine the Amount of Orally Administered Carbohydrates during Physical Exercise in Individuals with Type 1 Diabetes—A Randomized Cross-Over Trial
por: Moser, Othmar, et al.
Publicado: (2019)

Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp study
por: Eyileten, Ceren, et al.
Publicado: (2022)

Reduction in insulin degludec dosing for multiple exercise sessions improves time spent in euglycaemia in people with type 1 diabetes: A randomized crossover trial
por: Moser, Othmar, et al.
Publicado: (2018)

Assessment of Two Different Glucagon Assays in Healthy Individuals and Type 1 and Type 2 Diabetes Patients
por: Brunner, Martina, et al.
Publicado: (2022)

Albumin of People with Diabetes Mellitus Is More Reduced at Low HbA1c
por: Paar, Margret, et al.
Publicado: (2023)

Intermittent Fasting (Alternate Day Fasting) in Healthy, Non-obese Adults: Protocol for a Cohort Trial with an Embedded Randomized Controlled Pilot Trial
por: Tripolt, Norbert J., et al.
Publicado: (2018)

Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial
por: Aziz, Faisal, et al.
Publicado: (2023)

Identification of Novel Intronic SNPs in Transporter Genes Associated with Metformin Side Effects
por: Schweighofer, Natascha, et al.
Publicado: (2023)

Comment on: Davidson et al. High-Dose Vitamin D Supplementation in People With Prediabetes and Hypovitaminosis D. Diabetes Care 2013;36:260–266
por: Tripolt, Norbert J., et al.
Publicado: (2013)

Changes in Lipoprotein(a) Levels in People after ST Elevation Myocardial Infarction—The STEMI-Lipids Study
por: Sourij, Caren, et al.
Publicado: (2023)

The EndoBarrier: Duodenal-Jejunal Bypass Liner for Diabetes and Weight Loss
por: Ruban, Aruchuna, et al.
Publicado: (2018)

Feasibility and safety of using an automated decision support system for insulin therapy in the treatment of steroid‐induced hyperglycemia in patients with acute graft‐versus‐host disease: A randomized trial
por: Aberer, Felix, et al.
Publicado: (2018)

Multiple risk factor intervention reduces carotid atherosclerosis in patients with type 2 diabetes
por: Tripolt, Norbert J, et al.
Publicado: (2014)

Glucose-Lowering Therapy beyond Insulin in Type 1 Diabetes: A Narrative Review on Existing Evidence from Randomized Controlled Trials and Clinical Perspective
por: Aberer, Felix, et al.
Publicado: (2022)

Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot Study
por: Stadlbauer, Vanessa, et al.
Publicado: (2015)

Effects of a multispecies synbiotic on glucose metabolism, lipid marker, gut microbiome composition, gut permeability, and quality of life in diabesity: a randomized, double-blind, placebo-controlled pilot study
por: Horvath, Angela, et al.
Publicado: (2019)

A head‐to‐head comparison of personal and professional continuous glucose monitoring systems in people with type 1 diabetes: Hypoglycaemia remains the weak spot
por: Moser, Othmar, et al.
Publicado: (2018)

Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction – a post-hoc analysis of the EMMY trial
por: Benedikt, Martin, et al.
Publicado: (2023)

EndoBarrier®: a Safe and Effective Novel Treatment for Obesity and Type 2 Diabetes?
por: Patel, Nisha, et al.
Publicado: (2018)

Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial
por: Tripolt, Norbert J., et al.
Publicado: (2018)

Biomarkers Predictive for In-Hospital Mortality in Patients with Diabetes Mellitus and Prediabetes Hospitalized for COVID-19 in Austria: An Analysis of COVID-19 in Diabetes Registry
por: Aziz, Faisal, et al.
Publicado: (2022)

Association of HbA1c with VO(2max) in Individuals with Type 1 Diabetes: A Systematic Review and Meta-Analysis
por: Eckstein, Max L., et al.
Publicado: (2022)

The Arrhythmogenic Face of COVID-19: Brugada ECG Pattern in SARS-CoV-2 Infection
por: Zimmermann, Paul, et al.
Publicado: (2022)

A Practical Guide for the Management of Steroid Induced Hyperglycaemia in the Hospital
por: Aberer, Felix, et al.
Publicado: (2021)

Patients with healed diabetic foot ulcer represent a cohort at highest risk for future fatal events
por: Mader, Julia K., et al.
Publicado: (2019)

The effects of linagliptin on endothelial function and global arginine bioavailability ratio in coronary artery disease patients with early diabetes: study protocol for a randomized controlled trial
por: Tripolt, Norbert J., et al.
Publicado: (2016)

Timing of SGLT2i initiation after acute myocardial infarction
por: von Lewinski, Dirk, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2592ig93eo2jhs077b37jjap3s